| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 07/24/2001 | US6265426 Triazole derivatives |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/19/2001 | WO2001051645A1 Obg3 globular head and uses thereof for decreasing body mass |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001051492A1 Pyrazino-pyridazine derivatives as ligands for gaba receptors |
| 07/19/2001 | WO2001051471A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001005820A3 Method for down-regulating gdf-8 activity |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000064485A9 Specifically targeted catalytic antagonists and uses thereof |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/19/2001 | CA2396199A1 Pyrazino-pyridazine derivatives as ligands for gaba receptors |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115864A2 Human chaperone proteins |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115719A2 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 07/18/2001 | EP1115716A1 2-phenylpyran-4-one derivatives |
| 07/18/2001 | EP1115402A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas |
| 07/18/2001 | EP1115398A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 07/18/2001 | EP1115390A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/17/2001 | US6262096 Aminothiazole inhibitors of cyclin dependent kinases |
| 07/17/2001 | US6261560 Method for inhibiting muscle protein proteolysis with antibodies to interleukin-6 receptor |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049703A2 Substituted sapogenins and their use |
| 07/12/2001 | WO2001049323A1 Combination therapy for the treatment of inflammatory and respiratory diseases |
| 07/12/2001 | WO2001049309A2 Combinations of growth factors and i: upa or i: mmp for the treatment of damaged tissue |
| 07/12/2001 | WO2001049295A1 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 07/12/2001 | WO2001049288A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | WO2001002358A3 Cyclized amide derivatives for treating or preventing neuronal damage |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 07/12/2001 | WO2000074722A3 Modification of biological elements |
| 07/12/2001 | US20010007755 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/12/2001 | US20010007656 Introducing cells treated in vivo with DNA segment comprising transcription factor gene (c-Myc) and operably linked promoter sequence to patient |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2396393A1 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 07/12/2001 | CA2396257A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | CA2395487A1 Composition for the treatment of damaged tissue |
| 07/11/2001 | EP1114164A1 Atp synthase subunit homolog |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114156A2 Mammalian transforming growth factor beta - 9 (ztgfss9) |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114053A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 07/11/2001 | EP1114051A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1113807A2 Cell mediated gene delivery using muscle derived cells for treating muscle- and bone-related injury or dysfunction |
| 07/11/2001 | EP0969865A4 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 07/11/2001 | EP0801651B1 Hydroxymethylimidazodiazepines and their esters |
| 07/11/2001 | CN1303372A New heterocyclically substituted amides, their production and their use |
| 07/11/2001 | CN1303364A Aminocyclohexyl ether compounds and uses thereof |
| 07/11/2001 | CN1303281A Use of compounds for elevation of pyruvate dehydrogenase activity |
| 07/11/2001 | CN1302650A 'Hehe' ointment and its preparing process |
| 07/11/2001 | CN1302639A Tendon-conditioning analgetic |
| 07/11/2001 | CA2331012A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/10/2001 | US6258584 Drug screening for modulators of collagen formation by measuring enzyme activity in presence and absence of compound; reduced activity indicates enzyme inhibitor; antiarthritic agents; antiscarring agents |
| 07/05/2001 | WO2001048052A1 Branched polyalkylene glycols |
| 07/05/2001 | WO2001047914A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047901A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 07/05/2001 | WO2001047533A2 INHIBITION OF GSK-3$g(b) |
| 07/05/2001 | WO2001012592A3 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 07/05/2001 | WO2001003720A9 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 07/05/2001 | WO2001002363A3 N-substituted glycine derivatives |
| 07/05/2001 | WO2001000824A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 07/05/2001 | WO2000070046A3 Secreted polypeptides and corresponding polynucleotides |
| 07/05/2001 | WO2000059942A3 Human obesity protein binding protrein-2 homolog and uses thereof |
| 07/05/2001 | WO2000018799A9 Artemin, a novel neurotrophic factor |
| 07/05/2001 | CA2395663A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395284A1 Inhibition of gsk-3.beta. |
| 07/04/2001 | EP1112251A1 Azetidine derivatives, preparation and medicines containing them |
| 07/04/2001 | EP1112090A2 Method of stimulating prosaposin receptor activity |
| 07/04/2001 | EP1112082A2 Stable liquid formulations of botulinum toxin |
| 07/04/2001 | CN1302296A Novel 2-alkyl substituted imidazole compounds |
| 07/04/2001 | CN1302208A Smilagenin and anzurogenin-D for curing Alzheimer's disease |
| 06/28/2001 | WO2001046394A2 Mammalian protein phosphatases |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046146A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001045714A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045700A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045695A2 Calcium formate for use as a phosphorus binder and a dietary supplement |
| 06/28/2001 | WO2000075144A3 Peroxynitrite decomposition catalysts and methods of use thereof |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000067697A3 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 06/28/2001 | WO2000066104A3 Ace-2 inhibiting compounds and methods of use thereof |
| 06/28/2001 | US20010005719 Compositions and methods for treatment of mitochondrial diseases |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/27/2001 | EP1109907A1 Human cell junction pdz protein |
| 06/27/2001 | EP1109903A2 Human rna-associated proteins |
| 06/27/2001 | EP1109803A1 Substituted imidazoles having cytokine inhibitory activity |
| 06/27/2001 | EP1109453A1 Compositions and methods for treatment of mitochondrial diseases |
| 06/27/2001 | CN1301264A Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 06/27/2001 | CN1301255A Heterocyclically substituted amides, their production and their use |
| 06/27/2001 | CN1301166A Steroidal saponins for treating alzheimer's disease |
| 06/26/2001 | US6251917 Benzamidoaldehydes and their use as cysteine protease inhibitors |
| 06/26/2001 | US6251902 Dipeptide derivatives as growth hormone secretagogues |
| 06/21/2001 | WO2001044514A2 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 06/21/2001 | WO2001044473A2 Polypeptides and nucleic acids encoding same |